Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata (NCT07133308)
A Double-Blind, Randomized, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescent Patients With Severe Alopecia Areata With an Open-label Extension Period
🩺 Plain-English Summary (8th-Grade Level)
This study evaluates the safety and effectiveness of deuruxolitinib in adolescents aged 12 to less than 18 years who have 50% or greater scalp hair loss.
Who can join: Review the eligibility criteria below.
Location: Total Skin And Beauty Dermatology Center — Birmingham, Alabama
Age range: 12 Years to 17 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (64 Sites)
Showing the first 25 of 64 sites.
- Total Skin And Beauty Dermatology Center — Birmingham, Alabama
- Avacare - Cct Research - Center For Dermatology And Plastic Surgery — Scottsdale, Arizona
- Dermatology Trial Associates — Bryant, Arkansas
- Kern Research Inc. — Bakersfield, California
- Center For Dermatology Clinical Research Inc. — Fremont, California
- Dermatology Research Associates — Los Angeles, California
- Palmtree Clinical Research — Palm Springs, California
- Paradigm Clinical Research - San Diego — San Diego, California
- Colorado Medical Research Center — Denver, Colorado
- Paradigm Clinical Research - Wheat Ridge — Wheat Ridge, Colorado
- D&H Doral Research Center — Doral, Florida
- Skin Care Research, Llc - Hollywood — Hollywood, Florida
- Ilumina Medical Research Llc — Kissimmee, Florida
- All X Ray Diagnostic Services Corp — Miami, Florida
- Millennium Medical Research Llc — Miami, Florida
- Florida International Medical Research — Miami, Florida
- Florida Pharmaceutical Research And Associates, Inc. — Miami, Florida
- L&C Professional Medical Research Institute — Miami, Florida
- Pediatric Skin Research Llc — Miami, Florida
- Valencia Medical & Research Center — Miami, Florida
- Advance Research Center, Llc — Miami, Florida
- Barroso Medical Services Llc — Miami Lakes, Florida
- Nexus Research Llc — Pompano Beach, Florida
- International Clinical Research Us Llc - Sanford — Sanford, Florida
- Lenus Research & Medical Group Llc. — Sweetwater, Florida
📞 Contact the Study Coordinator
Phone: 9122 66455645
Email: Clinical.Trial@sunpharma.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Alopecia Areata
- Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata — Birmingham, Alabama
- A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo — Northridge, California
- A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA) — Northridge, California
- Alopecia Areata Registry — San Francisco, California
- Intralesional Cyclosporine for Alopecia Areata — Sacramento, California
- A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA) — Scottsdale, Arizona
Explore by condition: All Alopecia Areata clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.